Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis

Objectives To portray the stage characteristics of lung cancers detected in CT screenings, and explore whether there’s universal stage superiority over other methods for various pathological types using available data worldwide in a meta-analysis approach. Materials and Methods EMBASE and MEDLINE were searched for studies on lung cancer CT screening in natural populations through July 2015 without language or other filters. Twenty-four studies (8 trials and 16 cohorts) involving 1875 CT-detected lung cancer patients were enrolled and assessed by QUADAS-2. Pathology-confirmed stage information was carefully extracted by two reviewers. Stage I or limited stage proportions were pooled by random effect model with Freeman-Tukey double arcsine transformation. Results Pooled stage I cancer proportion in CT screenings was 73.2% (95% confidence interval: 68.6%, 77.5%), with a significant rising trend (Ptrend<0.05) from baseline (64.7%) to ≥5 repeat rounds (87.1%). Relative to chest radiograph and usual care, the increased stage I proportions in CT were 12.2% (P>0.05), and 46.5% (P<0.05), respectively. Pathology-specifically, adenocarcinomas (66%) and squamous cell lung cancers (17%) composed the majority of CT-detected lung cancers, and had significantly higher stage I proportions relative to chest radiograph (bronchioloalveolar adenocarcinomas, 80.9% vs 51.4%; other adenocarcinomas, 58.8% vs 38.3%; squamous cell lung cancers, 52.3% vs 38.3%; all P<0.05). However, the percentage of small cell lung cancer was lower using CT than other detection routes, and no significant difference in limited stage proportion was observed (6.8% vs 10.8%, P>0.05). Conclusion CT screening can detect more early stage non-small cell lung cancers, but not all of them could be beneficial as there are a considerable number of indolent ones such as bronchioloalveolar adenocarcinomas. Still, current evidence is lacking regarding small cell lung cancers.

[1]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[2]  K. Doi,et al.  Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers. , 2003, Academic radiology.

[3]  Mingzhu Liang,et al.  The outcome differences of CT screening for lung cancer pre and post following an algorithm in Zhuhai, China. , 2011, Lung cancer.

[4]  H. D. de Koning,et al.  Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. , 2014, The Lancet. Oncology.

[5]  T. Zdrojewski,et al.  Results of an open-access lung cancer screening program with low-dose computed tomography: the Gdańsk experience. , 2015, Polskie Archiwum Medycyny Wewnetrznej.

[6]  W. Heindel,et al.  Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers , 2004, European Radiology.

[7]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[8]  A. Dirksen,et al.  CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT , 2012, Thorax.

[9]  T. Mizoue,et al.  Low-dose Computed Tomography Screening in Japan , 2015, Journal of thoracic imaging.

[10]  F. Petrella,et al.  Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model. , 2013, Lung cancer.

[11]  G. Silvestri.  Screening for Lung Cancer: It Works, but Does It Really Work? , 2011, Annals of Internal Medicine.

[12]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  H. Kauczor,et al.  Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  Susan Mallett,et al.  Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles , 2014, PloS one.

[15]  Hajime Nakata,et al.  Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. , 2002, Chest.

[16]  David O Wilson,et al.  The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. , 2008, American journal of respiratory and critical care medicine.

[17]  R. Hopkins,et al.  Mortality Reduction, Overdiagnosis, and the Benefit-to-Harm Ratio of Computed Tomography Screening. , 2015, American journal of respiratory and critical care medicine.

[18]  David Spizarny,et al.  Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. , 2005, Lung cancer.

[19]  Brady J. McKee,et al.  Experience With a CT Screening Program for Individuals at High Risk for Developing Lung Cancer. , 2016, Journal of the American College of Radiology : JACR.

[20]  G. Bastarrika,et al.  Early lung cancer detection using spiral computed tomography and positron emission tomography. , 2005, American journal of respiratory and critical care medicine.

[21]  G. Byrnes,et al.  Screening for lung cancer. , 2004, The Cochrane database of systematic reviews.

[22]  M. Mascalchi,et al.  Four-Year Results of Low-Dose CT Screening and Nodule Management in the ITALUNG Trial , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  M. Aerts,et al.  Metaprop: a Stata command to perform meta-analysis of binomial data , 2014, Archives of Public Health.

[24]  W. Travis,et al.  Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study. , 2008, Lung cancer.

[25]  Kyung Soo Lee,et al.  Lung Cancer Screening with Low-Dose Helical CT in Korea: Experiences at the Samsung Medical Center , 2005, Journal of Korean medical science.

[26]  P. Bach.  Is our natural-history model of lung cancer wrong? , 2008, The Lancet. Oncology.

[27]  C. la Vecchia,et al.  Screening with Low‐Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[28]  Parminder Raina,et al.  Screening for lung cancer: A systematic review and meta-analysis. , 2016, Preventive medicine.

[29]  Alexander McGregor,et al.  Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. , 2010, Lung cancer.

[30]  Armando Santoro,et al.  A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. , 2009, American journal of respiratory and critical care medicine.

[31]  Ugo Pastorino,et al.  Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[32]  J. Austin,et al.  The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification , 2009 .

[33]  H. Ohmatsu,et al.  The adenocarcinoma-specific stage shift in the Anti-lung Cancer Association project: significance of repeated screening for lung cancer for more than 5 years with low-dose helical computed tomography in a high-risk cohort. , 2010, Lung cancer.

[34]  J. Sosna,et al.  Computed tomography screening for lung cancer: applicability of an international protocol in a single-institution environment. , 2006, Clinical lung cancer.

[35]  Rongwei Fu,et al.  Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation , 2013, Annals of Internal Medicine.

[36]  Experience with a CT screening program for individuals at high risk for developing lung cancer. , 2015, Journal of the American College of Radiology : JACR.

[37]  Dawei Yang.  Estimating overdiagnosis in low-dose computed tomography screening for lung cancer : a cohort study , 2013 .

[38]  Fenghai Duan,et al.  Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. , 2015, American journal of respiratory and critical care medicine.

[39]  Wei-zhi Tang,et al.  [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants]. , 2014, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[40]  A. Braillon.  Bronchioalveolar lung cancer: screening and overdiagnosis. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Anne-Marie Sykes,et al.  CT screening for lung cancer: five-year prospective experience. , 2005, Radiology.

[42]  Stage shift in computed tomography screening: possible role of indolent cancers, "histology shift," and overdiagnosis. , 2013, American journal of respiratory and critical care medicine.

[43]  A. Hackshaw,et al.  Research in progress—LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group , 2015, Thorax.

[44]  J. Mulshine,et al.  Issues with implementing a high‐quality lung cancer screening program , 2014, CA: a cancer journal for clinicians.

[45]  Steven Shapiro,et al.  Doubling times and CT screen–detected lung cancers in the Pittsburgh Lung Screening Study. , 2012, American journal of respiratory and critical care medicine.

[46]  Marek Kimmel,et al.  CT screening for lung cancer: the first ten years. , 2002, Cancer journal.

[47]  Ning Wu,et al.  Early detection of lung cancer: Low-dose computed tomography screening in China , 2015, Thoracic cancer.

[48]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[49]  G. Hillerdal.  Indolent Lung Cancers—Time for a Paradigm Shift: A Review , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[50]  David F Yankelevitz,et al.  Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. , 2009, Lung cancer.

[51]  M. Beasley,et al.  Bronchioloalveolar carcinoma: a review of current concepts and evolving issues. , 2009, Archives of pathology & laboratory medicine.

[52]  B. Kramer,et al.  Overdiagnosis in low-dose computed tomography screening for lung cancer. , 2014, JAMA internal medicine.